A new two-hit animal model for schizophrenia research: Consequences on social behavior
Status PubMed-not-MEDLINE Jazyk angličtina Země Nizozemsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
40525138
PubMed Central
PMC12169724
DOI
10.1016/j.ibneur.2025.05.012
PII: S2667-2421(25)00078-8
Knihovny.cz E-zdroje
- Klíčová slova
- Animal model, Oxytocin, Schizophrenia, Social behavior, Two-hit model, negative symptom,
- Publikační typ
- časopisecké články MeSH
Schizophrenia, a profoundly impactful neuropsychiatric disorder, has been the subject of extensive research using animal models. However, certain important aspects remain understudied, including assumed long-term consequences of psychotic episodes on negative symptoms development and progression. Addressing these limitations, we proposed a novel animal model in male rats based on early postnatal immune activation triggered by lipopolysaccharide (LPS), serving as the predisposing factor (1st hit). As the 2nd hit, representing psychotic-like episodes, we implemented a multi-episodic co-treatment with dizocilpine (MK-801) and amphetamine (AMP), spanning multiple developmental periods. The animals were tested in two social behavioral assays in adolescence and adulthood to investigate whether a social deficit would arise. In addition, we evaluated the level of oxytocin (OT), a neuropeptide relevant to social behavior, in selected brain regions. In the social interaction test, when animals could freely interact in the open field and express their social behavioral profile entirely, social behavior decreased in adolescent experimental animals. In the social approach test in the Y maze, all animals, irrespective of treatment, preferred conspecific over an indifferent object and novel rat over a familiar rat. Further, the results revealed that the OT content in the hypothalamus increased with age. In the proposed model, social interaction in the open field was decreased in adolescent but not in adult rats, indicating that the pharmacological manipulations caused only transient age-dependent changes. The study was thus in certain aspects successful in creating a novel approach to model social deficit potentially relevant to schizophrenia; other findings require further investigation.
Charles University 3rd Faculty of Medicine Ruska 87 Prague 100 00 Czech Republic
Institute of Physiology CAS Videnska 1083 Prague 142 20 Czech Republic
National Institute of Mental Health Topolova 748 Klecany 250 67 Czech Republic
Zobrazit více v PubMed
Andiné P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Mårtensson E., Sandberg M. Characterization of MK-801-induced behavior as a putative rat model of psychosis. J. Pharmacol. Exp. Ther. 1999;290:1393–1408. PubMed
Basta-Kaim A., Fijał K., Budziszewska B., Regulska M., Leśkiewicz M., Kubera M., Gołembiowska K., Lasoń W., Wȩdzony K. Prenatal lipopolysaccharide treatment enhances MK-801-induced psychotomimetic effects in rats. Pharmacol. Biochem. Behav. 2011;98:241–249. doi: 10.1016/j.pbb.2010.12.026. PubMed DOI
Bayer T.A., Falkai P., Maier W. Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the “Two hit hypothesis. J. Psychiatr. Res. 1999;33:543–548. doi: 10.1016/S0022-3956(99)00039-4. PubMed DOI
Bitanihirwe B.K., Peleg-Raibstein D., Mouttet F., Feldon J., Meyer U. Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology. 2010;35:2462–2478. doi: 10.1038/npp.2010.129. PubMed DOI PMC
Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun. 2010;24:881–897. doi: 10.1016/j.bbi.2010.03.005. PubMed DOI
Brenhouse H.C., Schwarz J.M. Immunoadolescence: Neuroimmune development and adolescent behavior. Neurosci. Biobehav. Rev. 2016 doi: 10.1016/j.neubiorev.2016.05.035. PubMed DOI PMC
Brown A.S. The environment and susceptibility to schizophrenia. Prog. Neurobiol. 2011 doi: 10.1016/j.pneurobio.2010.09.003. PubMed DOI PMC
Brunet-Gouet E., Decety J. Social brain dysfunctions in schizophrenia: a review of neuroimaging studies. Psychiatry Res. 2006;148:75–92. doi: 10.1016/j.pscychresns.2006.05.001. PubMed DOI
Bubeníková-Valešová V., Horáček J., Vrajová M., Höschl C. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci. Biobehav. Rev. 2008 doi: 10.1016/j.neubiorev.2008.03.012. PubMed DOI
Casey B.J., Duhoux S., Malter Cohen M. Adolescence: what do transmission, transition, and translation have to do with it? Neuron. 2010;67:749–760. doi: 10.1016/j.neuron.2010.08.033. PubMed DOI PMC
Cieslik P., Radulska A., Pelikant-Malecka I., Ploska A., Kalinowski L., Wieronska J.M. Reversal of MK-801-INduced Disruptions in Social Interactions and Working Memory with Simultaneous Administration of LY487379 and VU152100 in Mice. Int J. Mol. Sci. 2019;20:2781. doi: 10.3390/ijms20112781. PubMed DOI PMC
Clancy B., Finlay B.L., Darlington R.B., Anand K.J.S. Extrapolating brain development from experimental species to humans. Neurotoxicology. 2007;28:931–937. doi: 10.1016/j.neuro.2007.01.014. PubMed DOI PMC
Corcoran C., Walker E., Huot R., Mittal V., Tessner K., Kestler L., Malaspina D. The Stress Cascade and Schizophrenia: Etiology and Onset. Schizophr. Bull. 2003 doi: 10.1093/oxfordjournals.schbul.a007038. PubMed DOI
Crawley J.N. Behavioral phenotyping strategies for mutant mice. Neuron. 2008 doi: 10.1016/j.neuron.2008.03.001. PubMed DOI
Danysz W., Essmann U., Bresink I., Wilk R. Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav. 1994;48:111–118. doi: 10.1016/0091-3057(94)90506-1. PubMed DOI
de Moura Linck V., Herrmann A.P., Goerck G.C., Iwu M.M., Okunji C.O., Leal M.B., Elisabetsky E. The putative antipsychotic alstonine reverses social interaction withdrawal in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2008;32:1449–1452. doi: 10.1016/j.pnpbp.2008.04.013. PubMed DOI
Der-Avakian A., Markou A. Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats. Behav. Pharm. 2010;21:359–368. doi: 10.1097/FBP.0b013e32833c7cc8. PubMed DOI PMC
Doenni V.M., Gray J.M., Song C.M., Patel S., Hill M.N., Pittman Q.J. Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. Brain. Behav. Immun. 2016;58:237–247. doi: 10.1016/J.BBI.2016.07.152. PubMed DOI PMC
Douglas L.A., Varlinskaya E.I., Spear L.P. Rewarding properties of social interactions in adolescent and adult male and female rats: Impact of social versus isolate housing of subjects and partners. Dev. Psychobiol. 2004;45:153–162. doi: 10.1002/dev.20025. PubMed DOI
Ellenbroek B., Youn J. Rodent models in neuroscience research: is it a rat race? Dis. Model Mech. 2016;9:1079–1087. doi: 10.1242/dmm.026120. PubMed DOI PMC
Ellison G., Eison M.S., Huberman H.S. Stages of constant amphetamine intoxication: delayed appearance of abnormal social behaviors in rat colonies. Psychopharmacol. (Berl. ) 1978;56:293–299. doi: 10.1007/BF00432852. PubMed DOI
Engelmann M., Hädicke J., Noack J. Testing declarative memory in laboratory rats and mice using the nonconditioned social discrimination procedure. Nat. Protoc. 2011;6:1152–1162. doi: 10.1038/nprot.2011.353. PubMed DOI
Engelmann M., Wotjak C.T., Landgraf R. Social discrimination procedure: An alternative method to investigate juvenile recognition abilities in rats. Physiol. Behav. 1995;58:315–321. doi: 10.1016/0031-9384(95)00053-L. PubMed DOI
Feifel D., Shilling P.D., MacDonald K.A. Review of oxytocin’s effects on the positive, negative, and cognitive domains of schizophrenia. Biol. Psychiatry. 2016;79:222–233. doi: 10.1016/j.biopsych.2015.07.025. PubMed DOI PMC
Feigenson K.A., Kusnecov A.W., Silverstein S.M. Inflammation and the two-hit hypothesis of schizophrenia. Neurosci. Biobehav. Rev. 2014 doi: 10.1016/j.neubiorev.2013.11.006. PubMed DOI PMC
File S.E., Seth P. A review of 25 years of the social interaction test. Eur. J. Pharm. 2003 doi: 10.1016/S0014-2999(03)01273-1. PubMed DOI
Galic M.A., Riazi K., Heida J.G., Mouihate A., Fournier N.M., Spencer S.J., Kalynchuk L.E., Teskey G.C., Pittman Q.J. Postnatal inflammation increases seizure susceptibility in adult rats. J. Neurosci. 2008;28:6904–6913. doi: 10.1523/JNEUROSCI.1901-08.2008. PubMed DOI PMC
Gambill J.D., Kornetsky C. Effects of chronic d-amphetamine on social behavior of the rat: Implications for an animal model of paranoid schizophrenia. Psychopharmacol. 1976;50:215–223. doi: 10.1007/BF00426835. PubMed DOI
Gejman P.V., Sanders A.R., Duan J. The role of genetics in the etiology of schizophrenia. Psychiatr. Clin. North Am. 2010;33:35–66. doi: 10.1016/j.psc.2009.12.003. PubMed DOI PMC
Giedd J.N. The Teen Brain: Insights from Neuroimaging. J. Adolesc. Heal. 2008 doi: 10.1016/j.jadohealth.2008.01.007. PubMed DOI
Giovanoli S., Engler H., Engler A., Richetto J., Voget M., Willi R., Winter C., Riva M.A., Mortensen P.B., Schedlowski M., Meyer U. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science. 2013;80 doi: 10.1126/science.1228261. PubMed DOI
Gururajan A., Taylor D.A., Malone D.T. Current pharmacological models of social withdrawal in rats: relevance to schizophrenia. Behav. Pharm. 2010;21:690–709. doi: 10.1097/FBP.0b013e32833fa7df. PubMed DOI
Hambrecht M., Häfner H. Substance abuse and the onset of schizophrenia. Biol. Psychiatry. 1996;40:1155–1163. doi: 10.1016/S0006-3223(95)00609-5. PubMed DOI
Hanks A.N., Dlugolenski K., Hughes Z.A., Seymour P.A., Majchrzak M.J. Pharmacological disruption of mouse social approach behavior: relevance to negative symptoms of schizophrenia. Behav. Brain Res. 2013;252:405–414. doi: 10.1016/j.bbr.2013.06.017. PubMed DOI
Harvey L., Boksa P. Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders. Dev. Neurobiol. 2012;72:1335–1348. doi: 10.1002/dneu.22043. PubMed DOI
Hoertel N., Rotenberg L., Blanco C., Pascal de Raykeer R., Hanon C., Kaladjian A., Limosin F., CSA Study Group Psychiatric symptoms and quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study. Eur. Arch. Psychiatry Clin. Neurosci. 2020;270:673–688. doi: 10.1007/s00406-019-01026-9. PubMed DOI
Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. 2007;27:11496–11500. doi: 10.1523/JNEUROSCI.2213-07.2007. PubMed DOI PMC
Iovino M., Messana T., De Pergola G., Iovino E., Dicuonzo F., Guastamacchia E., Giagulli V.A., Triggiani V. The role of neurohypophyseal hormones vasopressin and oxytocin in neuropsychiatric disorders. Endocr., Metab. Immune Disord. - Drug Targets. 2018;18:341–347. doi: 10.2174/1871530318666180220104900. PubMed DOI
Johnson J.L., Buisman-Pijlman F.T. Adversity impacting on oxytocin and behaviour: timing matters. Behav. Pharm. 2016;27:659–671. doi: 10.1097/FBP.0000000000000269. PubMed DOI
Jones C.A., Watson D.J., Fone K.C. Animal models of schizophrenia. Br. J. Pharm. 2011;164:1162–1194. doi: 10.1111/j.1476-5381.2011.01386.x. PubMed DOI PMC
Kamińska K., Rogóz Z. The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats. Pharmacol. Rep. 2015;67:1183–1187. doi: 10.1016/j.pharep.2015.04.006. PubMed DOI
Kantrowitz J., Javitt D.C. Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Curr. Opin. Psychiatry. 2012;25:96–102. doi: 10.1097/YCO.0b013e32835035b2. PubMed DOI PMC
Kirsten T.B., Taricano M., Maiorka P.C., Palermo-Neto J., Bernardi M.M. Prenatal lipopolysaccharide reduces social behavior in male offspring. Neuroimmunomodulation. 2010;17:240–251. doi: 10.1159/000290040. PubMed DOI
Krach S., Paulus F.M., Bodden M., Kircher T. The rewarding nature of social interactions. Front. Behav. Neurosci. 2010 doi: 10.3389/fnbeh.2010.00022. PubMed DOI PMC
Kubesova A., Tejkalova H., Syslova K., Kacer P., Vondrousova J., Tyls F., Fujakova M., Palenicek T., Horacek J. Biochemical, histopathological and morphological profiling of a rat model of early immune stimulation: Relation to psychopathology. PLoS One. 2015;10 doi: 10.1371/journal.pone.0115439. PubMed DOI PMC
Lapish C.C., Ahn K.C., Chambers R.A., Ashby D.M., Ahn S., Phillips A.G. Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia. Neuropsychopharmacology. 2014;39:1754–1762. doi: 10.1038/npp.2014.23. PubMed DOI PMC
Lapiz-Bluhm M.D.S., Bondi C.O., Doyen J., Rodriguez G.A., Bédard-Arana T., Morilak D.A. Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. J. Neuroendocr. 2008 doi: 10.1111/j.1365-2826.2008.01772.x. PubMed DOI PMC
Latané B., Werner C. Social and nonsocial sources of attraction in rats. Psychon. Sci. 1971;24:147–148. doi: 10.3758/BF03331794. DOI
Lee H.J., Macbeth A.H., Pagani J.H., Scott Young W. Oxytocin: The great facilitator of life. Prog. Neurobiol. 2009 doi: 10.1016/j.pneurobio.2009.04.001. PubMed DOI PMC
Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., Koenig J.I. Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology. 2005;30:1883–1894. doi: 10.1038/sj.npp.1300722. PubMed DOI
Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 2002 doi: 10.1146/annurev.neuro.25.112701.142754. PubMed DOI
Manahan-Vaughan D., von Haebler D., Winter C., Juckel G., Heinemann U. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus. 2008;18:125–134. doi: 10.1002/hipo.20367. PubMed DOI
Manduca A., Carbone E., Schiavi S., Cacchione C., Buzzelli V., Campolongo P., Trezza V. The neurochemistry of social reward during development: What have we learned from rodent models? J. Neurochem. 2021;157:1408–1435. doi: 10.1111/jnc.15321. PubMed DOI
Maynard T.M., Sikich L., Lieberman J.A., LaMantia A.S. Neural development, cell-cell signaling, and the “two-hit” hypothesis of schizophrenia. Schizophr. Bull. 2001 doi: 10.1093/oxfordjournals.schbul.a006887. PubMed DOI
McCutcheon J.E., Marinelli M. Age matters. Eur. J. Neurosci. 2009;29:997–1014. doi: 10.1111/j.1460-9568.2009.06648.x. PubMed DOI PMC
McDougall S.A., Apodaca M.G., Park G.I., Teran A., Baum T.J., Montejano N.R. MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems. Psychopharmacol. (Berl. ) 2020;237:2469–2483. doi: 10.1007/s00213-020-05547-3. PubMed DOI PMC
Meyer U. Developmental neuroinflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2013;42:20–34. doi: 10.1016/j.pnpbp.2011.11.003. PubMed DOI
Mikulecka A., Druga R., Stuchlik A., Mares P., Kubova H. Comorbidities of early-onset temporal epilepsy: Cognitive, social, emotional, and morphologic dimensions. Exp. Neurol. 2019;320 doi: 10.1016/j.expneurol.2019.113005. PubMed DOI
Mikulecká A., Mareš P. NMDA receptor antagonists impair motor performance in immature rats. Psychopharmacol. (Berl. ) 2002;162:364–372. doi: 10.1007/s00213-002-1122-2. PubMed DOI
Mikulecka A., Subrt M., Parizkova M., Mares P., Kubova H. Consequences of early postnatal benzodiazepines exposure in rats. II. Social behavior. Front Behav. Neurosci. 2014;8:169. doi: 10.3389/fnbeh.2014.00169. PubMed DOI PMC
Miller D.W., Abercrombie E.D. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats. Brain Res. Bull. 1996;40:57–62. doi: 10.1016/0361-9230(95)02144-2. PubMed DOI
Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., Piven J., Crawley J.N. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes, Brain Behav. 2004;3:287–302. doi: 10.1111/j.1601-1848.2004.00076.x. PubMed DOI
Owen M.J., Sawa A., Mortensen P.B. Schizophrenia. Lancet. 2016;388:86–97. doi: 10.1016/S0140-6736(15)01121-6. PubMed DOI PMC
Pešić V., Popić J., Milanović D., Lončarević-Vasiljković N., Rakić L., Kanazir S., Ruždijić S. The effect of MK-801 on motor activity and c-Fos protein expression in the brain of adolescent Wistar rats. Brain Res. 2010;1321:96–104. doi: 10.1016/j.brainres.2010.01.048. PubMed DOI
Peters S.M., Tuffnell J.A., Pinter I.J., van der Harst J.E., Spruijt B.M. Short- and long-term behavioral analysis of social interaction, ultrasonic vocalizations and social motivation in a chronic phencyclidine model. Behav. Brain Res. 2017;325:34–43. doi: 10.1016/j.bbr.2017.02.027. PubMed DOI
Porcelli S., Van Der Wee N., van der Werff S., Aghajani M., Glennon J.C., van Heukelum S., Mogavero F., Lobo A., Olivera F.J., Lobo E., Posadas M., Dukart J., Kozak R., Arce E., Ikram A., Vorstman J., Bilderbeck A., Saris I., Kas M.J., Serretti A. Social brain, social dysfunction and social withdrawal. Neurosci. Biobehav. Rev. 2019 doi: 10.1016/j.neubiorev.2018.09.012. PubMed DOI
Potasiewicz A., Holuj M., Litwa E., Gzielo K., Socha L., Popik P., Nikiforuk A. Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: behavioural and biochemical studies. Neuropharmacology. 2020;170 doi: 10.1016/j.neuropharm.2020.108040. PubMed DOI
Rich M.E., Caldwell H.K. A role for oxytocin in the etiology and treatment of schizophrenia. Front Endocrinol. 2015;6:90. doi: 10.3389/fendo.2015.00090. PubMed DOI PMC
Richetto J., Labouesse M.A., Poe M.M., Cook J.M., Grace A.A., Riva M.A., Meyer U. Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2’F-S-CH3 in an immune-mediated neurodevelopmental disruption model. Int. J. Neuropsychopharmacol. 2015;18 doi: 10.1093/ijnp/pyu055. pyu055. PubMed DOI PMC
Rubin L.H., Carter C.S., Drogos L., Pournajafi-Nazarloo H., Sweeney J.A., Maki P.M. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr. Res. 2010;124:13–21. doi: 10.1016/j.schres.2010.09.014. PubMed DOI PMC
Rung J.P., Carlsson A., Markinhuhta K.R., Carlsson M.L. + )-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005;29:827–832. doi: 10.1016/J.PNPBP.2005.03.004. PubMed DOI
Sams-Dodd F. MK-801 and phencyclidine induced neurotoxicity do not cause enduring behaviours resembling the positive and negative symptoms of schizophrenia in the rat. Basic Clin. Pharmacol. Toxicol. 2004;95:241–246. doi: 10.1111/j.1742-7843.2004.pto950507.x. PubMed DOI
Sams-Dodd F. Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats. Neuropsychopharmacology. 1998;19:18–25. doi: 10.1016/S0893-133X(97)00200-5. PubMed DOI
Sasayama D., Hattori K., Teraishi T., Hori H., Ota M., Yoshida S., Arima K., Higuchi T., Amano N., Kunugi H. Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia. Schizophr. Res. 2012;139:201–206. doi: 10.1016/j.schres.2012.06.016. PubMed DOI
Semple B.D., Blomgren K., Gimlin K., Ferriero D.M., Noble-Haeusslein L.J. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 2013 doi: 10.1016/j.pneurobio.2013.04.001. PubMed DOI PMC
Shepherd M., Watt D., Falloon I., Smeeton N. The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychol. Med. Monogr. Suppl. 1989;15:1–46. doi: 10.1017/s026418010000059x. PubMed DOI
Siviy S.M., Panksepp J. In search of the neurobiological substrates for social playfulness in mammalian brains. Neurosci. Biobehav Rev. 2011;35:1821–1830. doi: 10.1016/j.neubiorev.2011.03.006. PubMed DOI
Šlamberová R., Mikulecká A., Macúchová E., Hrebíčková I., Ševčíková M., Nohejlová K., Pometlová M. Effects of psychostimulants on social interaction in adult male rats. Behav. Pharm. 2015;26:776–785. doi: 10.1097/FBP.0000000000000148. PubMed DOI
Šlamberová R., Pometlová M., Macúchová E., Nohejlová K., Stuchlík A., Valeš K. Do the effects of prenatal exposure and acute treatment of methamphetamine on anxiety vary depending on the animal model used? Behav. Brain Res. 2015;292:361–369. doi: 10.1016/j.bbr.2015.07.001. PubMed DOI
Slováková A., Kúdelka J., Škoch A., Jakob L., Fialová M., Fürstová P., Bakštein E., Bankovská Motlová L., Knytl P., Španiel F. Time is the enemy: negative symptoms are related to even slight differences in the duration of untreated psychosis. Compr. Psychiatry. 2024;130 doi: 10.1016/j.comppsych.2024.152450. PubMed DOI
Solmi M., Seitidis G., Mavridis D., Correll C.U., Dragioti E., Guimond S., Tuominen L., Dargél A., Carvalho A.F., Fornaro M., Maes M., Monaco F., Song M., Il Shin J., Cortese S. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the global burden of disease (GBD) 2019. Mol. Psychiatry. 2023;28:5319–5327. doi: 10.1038/s41380-023-02138-4. PubMed DOI
Spencer S.J., Mouihate A., Galic M.A., Ellis S.L., Pittman Q.J. Neonatal immune challenge does not affect body weight regulation in rats. Am. J. Physiol. - Regul. Integr. Comp. Physiol. 2007;293:R581–9. doi: 10.1152/ajpregu.00262.2007. PubMed DOI
Stilo S.A., Murray R.M. Non-genetic factors in schizophrenia. Curr. Psychiatry Rep. 2019 doi: 10.1007/s11920-019-1091-3. PubMed DOI PMC
Szeto A., McCabe P.M., Nation D.A., Tabak B.A., Rossetti M.A., McCullough M.E., Schneiderman N., Mendez A.J. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom. Med. 2011;73:393–400. doi: 10.1097/PSY.0b013e31821df0c2. PubMed DOI PMC
Trezza V., Damsteegt R., Achterberg E.J., Vanderschuren L.J. Nucleus accumbens μ-opioid receptors mediate social reward. J. Neurosci. 2011;31:6362–6370. doi: 10.1523/JNEUROSCI.5492-10.2011. PubMed DOI PMC
van der Kooij M.A., Sandi C. Social memories in rodents: methods, mechanisms and modulation by stress. Neurosci. Biobehav. Rev. 2012;36:1763–1772. doi: 10.1016/J.NEUBIOREV.2011.10.006. PubMed DOI
Vasilev V., Veskov R., Janać B., Rakić L., Stojiljković M. Age-related differences in MK-801- and amphetamine-induced locomotor and stereotypic activities of rats. Neurobiol. Aging. 2003;24:715–723. doi: 10.1016/S0197-4580(02)00232-4. PubMed DOI
Vojtechova I., Maleninska K., Kutna V., Klovrza O., Tuckova K., Petrasek T., Stuchlik A. Behavioral alterations and decreased number of parvalbumin-positive interneurons in wistar rats after maternal immune activation by lipopolysaccharide: sex matters. Int. J. Mol. Sci. 2021;22:3274. doi: 10.3390/ijms22063274. PubMed DOI PMC
Vojtechova I., Petrasek T., Maleninska K., Brozka H., Tejkalova H., Horacek J., Stuchlik A., Vales K. Neonatal immune activation by lipopolysaccharide causes inadequate emotional responses to novel situations but no changes in anxiety or cognitive behavior in Wistar rats. Behav. Brain Res. 2018;349:42–53. doi: 10.1016/j.bbr.2018.05.001. PubMed DOI
Weber-Stadlbauer U., Richetto J., Labouesse M.A., Bohacek J., Mansuy I.M., Meyer U. Transgenerational transmission and modification of pathological traits induced by prenatal immune activation. Mol. Psychiatry. 2017;22:102–112. doi: 10.1038/mp.2016.41. PubMed DOI
Wegener N., Nagel J., Gross R., Chambon C., Greco S., Pietraszek M., Gravius A., Danysz W. Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour. Neurosci. Lett. 2011;503:68–72. doi: 10.1016/j.neulet.2011.08.012. PubMed DOI
Wicks S., Hjern A., Gunnell D., Lewis G., Dalman C. Social adversity in childhood and the risk of developing psychosis: a national cohort study. Am. J. Psychiatry. 2005;162:1652–1657. doi: 10.1176/appi.ajp.162.9.1652. PubMed DOI
Wiersma D., Nienhuis F.J., Slooff C.J., Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr. Bull. 1998;24:75–85. doi: 10.1093/oxfordjournals.schbul.a033315. PubMed DOI
Wilson C.A., Koenig J.I. Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia. Eur. Neuropsychopharmacol. 2014;24:759–773. doi: 10.1016/j.euroneuro.2013.11.008. PubMed DOI PMC
Winship I.R., Dursun S.M., Baker G.B., Balista P.A., Kandratavicius L., Maia-de-Oliveira J.P., Hallak J., Howland J.G. An overview of animal models related to schizophrenia. Can. J. Psychiatry. 2019;64:5–17. doi: 10.1177/0706743718773728. PubMed DOI PMC
Wyatt R.J. Neuroleptics and the natural course of schizophrenia. Schizophr. Bull. 1991;17:325–351. doi: 10.1093/schbul/17.2.325. PubMed DOI
Yamamuro Y. Social behavior in laboratory rats: applications for psycho-neuroethology studies. Anim. Sci. J. 2006 doi: 10.1111/j.1740-0929.2006.00363.x. DOI
Yu M., Tan Q., Wang Y., Xu Y., Wang T., Liu D., Chen D., Deng P., Huang C., Liang X., Liu K., Xiang B. Correlation between duration of untreated psychosis and long-term prognosis in chronic schizophrenia. Front. Psychiatry. 2023;14 doi: 10.3389/fpsyt.2023.1112657. PubMed DOI PMC